Psychiatric Aspects of Heart and Lung Disease in Critical Care

Critical Care Clinics

Volumn 24, Issue 4, 2008, Pages 921-947

  Shapiro, Peter A ^a,b   Fedoronko, David A ^a,b   Epstein, Lucy A ^a,b   Mirasol, Elsa G E ^c   Desai, Chirag V ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ARIPIPRAZOLE; BENZODIAZEPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; CORTICOSTEROID; DEXMEDETOMIDINE; HALOPERIDOL; LORAZEPAM; METHYLPHENIDATE; METHYLXANTHINE; MIRTAZAPINE; NEUROLEPTIC AGENT; NITRATE; OLANZAPINE; PHENOBARBITAL; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE RESPIRATORY FAILURE; ALCOHOL WITHDRAWAL; ANXIETY; ANXIETY DISORDER; ARTIFICIAL VENTILATION; BRADYCARDIA; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CORONARY ARTERY BYPASS GRAFT; DELIRIUM; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEAR; HEART ARREST; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; INTENSIVE CARE; IRRITABILITY; MENTAL DISEASE; METABOLIC SYNDROME X; PAIN; PANIC; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RESTLESSNESS; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; TERMINAL CARE; TORSADE DES POINTES; TREMOR; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; CRITICAL CARE; DELIRIUM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; MALE; SEVERITY OF ILLNESS INDEX;

EID: 53249124716     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.05.003     Document Type: Review

References (135)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. [Text Revision] (2000), American Psychiatric Association, Washington, D.C.
2. Goodwin R.D., and Pine D.S. Respiratory disease and panic attacks among adults in the United States. Chest 122 (2002) 645-650
3. Karajgi B., Rifkin A., Doddi S., et al. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 147 (1990) 200-201
4. Janson C., Björnsson E., Hetta J., et al. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med 149 (1994) 930-934
5. Yellowlees P.M., Alpers J.H., Bowden J.J., et al. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 146 (1987) 305-307
6. Smoller J.W., Pollack M.H., Otto M.W., et al. Panic anxiety, dyspnea, and respiratory disease. Am J Respir Crit Care Med 154 (1996) 6-17
7. Clark D.M. A cognitive approach to panic. Behav Res Ther 24 (1986) 461-470
8. Pitts F.N., and McClure J.N. Lactate metabolism in anxiety neurosis. N Engl J Med 277 (1967) 1329-1336
9. Cowley D.S., and Arana G.W. The diagnostic utility of lactate sensitivity in panic disorder. Arch Gen Psychiatry 47 (1990) 277-284
10. 2. Br J Psychiatry 144 (1984) 503-507
11. Papp L.A., Klein D.F., Martinez J., et al. Diagnostic and substance specificity of carbon dioxide induced panic. Am J Psychiatry 150 (1993) 250-257
12. Papp L.A., Klein D.F., and Gorman J.M. Carbon dioxide hypersensitivity, hyperventilation and panic disorder. Am J Psychiatry 150 (1993) 1149-1157
13. Elam M., Yao T., Thorén P., et al. Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves. Brain Res 222 (1981) 373-381
14. Gorman J.M., Fyer M.R., Goetz R., et al. Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45 (1988) 31-39
15. Thompson W.L., and Thompson T.L. Use of medications in patients with chronic pulmonary disease. Adv Psychosom Med 14 (1985) 136-148
16. In: Brunton L.L. (Ed). Goodman & Gilman's the pharmacologic basis of therapeutics (2006), McGraw Hill, New York 253, 729
17. Cox B.J., Norton G.R., Swinson R.P., et al. Substance abuse and panic related anxiety: a critical review. Behav Res Ther 28 (1990) 385-393
18. Cosci F., Schruers K.R., Abrams K., et al. Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J Clin Psychiatry 68 (2007) 874-880
19. O'Brien C.P. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66 Suppl 2 (2005) 28-33
20. Geddes D.M., Rudolf M., and Saunders K.B. Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax 31 (1976) 548-551
21. Mitchell-Heggs P., Murphy K., Minty K., et al. Diazepam in the treatment of the pink puffer syndrome. Q J Med 49 (1980) 9-20
22. Man G.C., Hsu K., and Sproule B. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 90 (1986) 832-836
23. Argyropoulou P., Patakas D., Koukou A., et al. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 60 (1993) 216-220
24. Brenes G. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 65 (2003) 963-970
25. In: Ropper A.H., and Brown R.H. (Eds). Adams and Victor's principles of neurology (2005), McGraw-Hill, New York 964
26. Murray M.J., DeRuyter M.L., and Harrison B.A. Opioids and benzodiazepines. Crit Care Clin 11 (1995) 849-873
27. Bergbom-Engberg I., and Haljamae H. Assessment of patients' experience of discomfort during respirator therapy. Crit Care Med 17 (1989) 1068-1072
28. Aurell J., and Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Brit Med J (Clin Res Ed) 290 (1985) 1029-1032
29. Friese R.S., Diaz-Arrastia R., McBride D., et al. Quantity and quality of sleep in the surgical intensive care unit: are our patients sleeping?. J Trauma 63 (2007) 1210-1214
30. Johnson M.M., and Sexton D.L. Distress during mechanical ventilation: patient's perceptions. Crit Care Nurse 10 (1990) 48-57
31. Gale J., and O'Shanick G.J. Psychiatric aspects of respirator treatment and pulmonary intensive care. Adv Psychosom Med 14 (1985) 93-108
32. Castillo A., and Egan H. How it feels to be a ventilator patient. Respiratory Care 19 (1974) 289-293
33. Connelly B., Gunzerath L., and Knebel A. A pilot study exploring mood state and dyspnea in mechanically ventilated patients. Heart Lung 29 (2000) 173-179
34. Rea R.S., Battistone S., Fong J.J., et al. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy 27 (2007) 588-594
35. Mendel J., and Kahn F. Psychological aspects of weaning from mechanical ventilation. Psychosomatics 21 (1980) 465-471
36. Johnson C.J., Auger W.R., Fedullo P.F., et al. Methylphenidate in the hard to wean patient. J Psychosom Res 39 (1994) 63-68
37. Rothenhäusler H.B., Ehrentraut S., von Degenfeld G., et al. Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit. J Clin Psychiatry 61 (2000) 750-755
38. Fontaine D.K. Nonpharmacologic management of patient distress during mechanical ventilation. Crit Care Clin 10 (1994) 695-708
39. Kawachi I., Colditz G.A., Ascherio A., et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89 (1994) 1992-1997
40. Kawachi I., Sparrow D., Vokonas P.S., et al. Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 90 (1994) 2225-2229
41. Barefoot J.C., Dahlstrom W.G., and Williams R.B. Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. Psychosom Med 45 (1983) 59-63
42. Shekelle R.B., Gale M., Ostfeld A.M., et al. Hostility, risk of coronary heart disease, and mortality. Psychosom Med 45 (1983) 109-114
43. Kawachi I., Sparrow D., Spiro III A., et al. A prospective study of anger and coronary heart disease: the Normative Aging Study. Circulation 94 (1996) 2090-2095
44. Williams J.E., Paton C.C., Siegler I.C., et al. Anger proneness predicts coronary heart disease risk: prospective Analysis from the Atherosclerosis Risk In Communities (ARIC) study. Circulation 101 (2000) 2034-2039
45. Matthews K.A., Gump B.B., Harris K.F., et al. Hostile behaviors predict cardiovascular mortality among men enrolled in the multiple risk factor intervention trial. Circulation 109 (2004) 66-70
46. Schulman J.K., Muskin P.R., and Shapiro P.A. Psychiatry and cardiovascular disease. Focus 3 (2005) 208-224
47. Anda R., Williamson D., Jones D., et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4 (1993) 285-294
48. Shapiro P.A., Lidagoster L., and Glassman A.H. Depression and heart disease. Psychiatr Ann 27 (1997) 347-352
49. Glassman A.H., and Shapiro P.A. Depression and the course of coronary artery disease. Am J Psychiatry 155 (1998) 4-11
50. Appels A., and Otten F. Exhaustion as precursor of cardiac death. Br J Clin Psychol 31 (1992) 351-356
51. Denollet J., Sys S.U., and Brutsaert D.L. Personality and mortality after myocardial infarction. Psychosom Med 57 (1995) 582-591
52. Denollet J., and Brutsaert D. Personality, disease severity, and the risk of long-term cardiac events with a decreased ejection fraction after myocardial infarction. Circulation 97 (1998) 167-173
53. Rozanski A., Blumenthal J.A., and Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999) 2192-2217
54. Rozanski A., Blumenthal J.A., Davidson K.W., et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45 (2005) 637-651
55. Hance M., Carney R.M., Freedland K.E., et al. Depression in patients with coronary heart disease. Gen Hosp Psychiatry 18 (1996) 61-65
56. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 270 (1993) 1819-1825
57. Lesperance F., Frasure-Smith N., and Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 58 (1996) 99-110
58. Moser D.K., and Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?. Psychosom Med 58 (1996) 395-401
59. Frasure-Smith N., Lesperance F., and Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?. Heath Psychol 14 (1995) 388-398
60. Frasure-Smith N., and Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 65 (2008) 62-71
61. Bambauer K.Z., Aupont O., Stone P.H., et al. The effect of a telephone counseling intervention on self-rated health of cardiac patients. Psychosom Med 67 (2005) 539-545
62. Kanji N., White A.R., and Ernst E. Autogenic training reduces anxiety after coronary angioplasty: a randomized clinical trial. Am Heart J 147 (2004) E10
63. Lie I., Arnesen H., Sandvik L., et al. Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res 62 (2007) 411-418
64. Shapiro P.A. Heart disease. In: Levenson J.L. (Ed). APPI Textbook of Psychosomatic Medicine (2004), APPI, Washington, D.C. 423-444
65. Shapiro P.A. Psychiatric aspects of cardiovascular disease. Psychiatr Clin North Am 19 (1996) 613-629
66. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
67. Wulsin L.R., Vaillant G.E., and Wells V.E. A systematic review of the mortality of depression. Psychosom Med 61 (1999) 6-17
68. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis following myocardial infarction. Circulation 91 (1995) 999-1005
69. Lesperance F., Frasure-Smith N., Juneau M., et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med 160 (2000) 1354-1360
70. Lesperance F., Frasure-Smith N., Talajic M., et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105 (2002) 1049-1053
71. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161 (2001) 1849-1856
72. Faris R., Purcell H., Henein M.Y., et al. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 4 (2002) 541-551
73. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 55 (1998) 580-592
74. Carney R.M., Freedland K.E., Miller G.E., et al. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 53 (2002) 897-902
75. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 160 (2000) 1818-1823
76. Kronish I.M., Rieckmann N., Halm E.A., et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 21 (2006) 1178-1183
77. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
78. Glassman A.H., Bigger Jr. J.T., Gaffney M., et al. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 63 (2006) 283-288
79. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery In Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 289 (2003) 3106-3116
80. Lesperance F., Frasure-Smith N., Koszycki D., et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (create) trial. JAMA 297 (2007) 367-379
81. Honig A., Kuyper A.M., Schene A.H., et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 69 (2007) 606-613
82. de Jonge P., Honig A., van Melle J.P., et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 164 (2007) 1371-1378
83. Carney R.M., Blumenthal J.A., Freedland K.E., et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study. Psychosom Med 66 (2004) 466-474
84. Connerney I., Shapiro P.A., McLaughlin J.S., et al. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 358 (2001) 1766-1771
85. Blumenthal J.A., Lett H.S., Babyak M.A., et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 (2003) 604-609
86. Xiong G.L., Jiang W., Clare R., et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 98 (2006) 42-47
87. Mittal D., Majithia D., Kennedy R., et al. Differences in characteristics and outcome of delirium as based on referral patterns. Psychosomatics 47 (2006) 367-375
88. Mirasol E.G., Shapiro P.A., and Fang Y. Delirium in the cardiothoracic ICU: prevalence, predictors, and effect on length of stay (2007), Academy of Psychosomatic Medicine, Amelia Island (FL)
89. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 (2004) 1753-1762
90. Leslie D.L., Marcantonio E.R., Zhang Y., et al. One-year health care costs associated with delirium in the elderly population. Arch Intern Med 168 (2008) 27-32
91. van der Mast R.C., and Roest F.H. Delirium after cardiac surgery: a critical review. J Psychosom Res 41 (1996) 13-30
92. Norkiene I., Ringaitiene D., Misiuriene I., et al. Incidence and precipitating factors of delirium after coronary artery bypass grafting. Scand Cardiovasc J 41 (2007) 180-185
93. Giltay E.J., Huijskes R.V., Kho K.H., et al. Psychotic symptoms in patients undergoing coronary artery bypass grafting and heart valve operation. Eur J Cardiothorac Surg 30 (2006) 140-147
94. Kornfeld D.S., Zimberg S., and Malm J.R. Psychiatric complications of open heart surgery. N Engl J Med 273 (1965) 287-292
95. Inouye S.K., and Charpenter P.A. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 275 (1996) 852-857
96. Gunther M.L., Morandi A., and Ely E.W. Pathophysiology of delirium in the intensive care unit. Crit Care Clin 24 (2008) 45-65
97. Young J., and Inouye S.K. Delirium in older people. BMJ 334 (2007) 842-846
98. Kazmierski J., Kowman M., Banach M., et al. Preoperative predictors of delirium after cardiac surgery: a preliminary study. Gen Hosp Psychiatry 28 (2006) 536-538
99. Prakanrattana U., and Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 35 (2007) 714-719
100. Straker D.A., Shapiro P.A., and Muskin P.M. Aripiprazole in the treatment of delirium. Psychosomatics 47 (2006) 385-391
101. Maldonado J, Wysong A, van der Starre PJA, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics, in press.
102. Gerlach A.T., and Dasta J.F. Dexmedetomidine: an updated review. Ann Pharmacother 41 (2007) 245-252
103. Arpino K.A., Kalafatas K., and Thompson B.T. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit. J Clin Pharm Ther 33 (2008) 25-30
104. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298 (2007) 2644-2653
105. MacLaren R., Forrest L., and Kiser T.H. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 27 (2007) 351-359
106. Shah A.N., Koneru J., Nicoara A., et al. Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker: a cautionary tale. Pacing Clin Electrophysiol 30 (2007) 1158-1160
107. Corbett S.M., Rebuck J.A., Greene C.M., et al. Dexmedetomidine does not improve patient satisfaction when compared to propofol during mechanical ventilation. Crit Care Med 33 (2005) 940-945
108. Herr D.L., Sum-Ping S.T., and England M. ICU sedation after coronary artery bypass surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 17 (2003) 576-584
109. Newman M.F., Kirchner J.L., Phillips-Bute B., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344 (2001) 395-402
110. Roach G.W., Kanchuger M., Mangano C.M., et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 335 (1996) 1857-1863
111. Shapiro P.A., Levin H.R., and Oz M.C. Left ventricular assist devices: psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry 18 (1996) 30S-35S
112. Diegeler A., Hirsch R., Schneider F., et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg 69 (2000) 1162-1166
113. Van Dijk D., Jansen E.W., Hijman R., et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 287 (2002) 1405-1412
114. Sellke F.W., DiMaio J.M., Caplan L.R., et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association Council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 111 (2005) 2858-2864
115. Lazar R.M., Shapiro P.A., Jaski B.E., et al. Neurological events during long-term mechanical circulatory support for heart failure: the REMATCH experience. Circulation 109 (2004) 2423-2427
116. O'Brien J.M., Lu B., Ali N.A., et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 35 (2007) 345-350
117. Moore R.D., Bone L., Geller G., et al. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 261 (1989) 403-407
118. Blondell R.D., Looney S.W., Hottman L.M., et al. Characteristics of intoxicated trauma patients. J Addict Dis 21 (2002) 1-12
119. Marik P., and Mohedin B. Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol Alcohol 31 (1996) 393-396
120. Cammarano W.B., Pittet J.F., Weitz S., et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care patients. Crit Care Med 26 (1998) 676-684
121. Bateson A.N. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8 (2002) 5-21
122. Katzung B.G., and Trevor A. Sedative-hypnotic drugs: examination and board review pharmacology (1998), McGraw-Hill, New York p. 171-8
123. Morgan W.W. Abuse liability of barbiturates and other sedative-hypnotics. Adv Alcohol Subst Abuse 9 (1990) 67-82
124. Zawertailo L.A., Busto U.E., Kaplan H.L., et al. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. J Clin Psychopharmacol 23 (2003) 269-289
125. Krystal J.H., Staley J., Mason G., et al. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 63 (2006) 957-968
126. DeCarolis D.D., Rice K.L., Ho L., et al. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy 27 (2007) 510-518
127. Gold J.A., Rimal B., Nolan A., et al. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 35 (2007) 724-730
128. Crippen D. Life-threatening brain failure and agitation in the intensive care unit. Crit Care 4 (2000) 81-90
129. Kahkonen S. Responses to cardiovascular drugs during alcohol withdrawal. Alcohol Alcohol 41 (2006) 11-13
130. Lineaweaver W.C., Anderson K., and Hing D.N. Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med 16 (1988) 294-295
131. Pao M., Ballard E.D., Raza H., et al. Pediatric psychosomatic medicine: an annotated bibliography. Psychosomatics 48 (2007) 195-204
132. Pao M., Ballard E.D., and Rosenstein D.L. Growing up in the hospital. JAMA 297 (2007) 2752-2755
133. Shapiro P.A. Life after heart transplantation. Prog Cardiovasc Dis 32 (1990) 405-418
134. Weill C.M., Rodgers S., and Rubovits S. School re-entry of the pediatric heart transplant recipient. Pediatr Transplant 10 (2006) 928-933
135. Collier J.A., Nathanson J.W., and Anderson C.A. Personality functioning in adolescent heart transplant recipients. Clin Child Psychol Psychiatry 4 (1999) 367-377